Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Tepotinib
Tepotinib
1100598-32-0
|
492.572
|
3.397
Tepotinib is an oral tyrosine kinase inhibitor targeted against MET (Hepatocyte growth factor receptor) for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations.
EMD 1214063 | MSC2156119 | MSC2156119J | tepotinib
Tepotinib is an oral tyrosine kinase inhibitor targeted against MET (Hepatocyte growth factor receptor) for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations.
EMD 1214063 | MSC2156119 | MSC2156119J | tepotinib
$130/5 mg
(EBC)
1
We provide 0 compound for Tepotinib